Concepedia

Gaurav Chatterjee

GC

34

Publications

1.1K

Citations

19

H-Index

1959

Active since

Affiliations

Tata Memorial Hospital(Current)

Homi Bhabha National Institute

Advanced Centre for Treatment, Research and Education in Cancer

University of Calcutta

HCG Cancer Hospital

Gaurav Chatterjee is an author at Tata Memorial Hospital specializing in biochemistry, physiology, and medicine.

ORCID

Top concepts

Publications per year

1959–2023

34

Publications

34

Poly(ether urethane) and poly(ether urethane urea) membranes with high H2S/CH4 selectivity

Gaurav Chatterjee, A.A. Houde, S. A. Stern · Journal of Membrane Science · 1997 · 148 citations · Full text

Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)

Nikhil Patkar, Chinmayee Kakirde, Anam Fatima Shaikh et al. · Leukemia · 2021 · 92 citations · Full text

Biological synthesis of <scp>l</scp>-ascorbic acid in animal tissues: conversion of <scp>l</scp>-gulonolactone into <scp>l</scp>-ascorbic acid

Ipsita Chatterjee, Gaurav Chatterjee, Nilanjana Ghosh et al. · Biochemical Journal · 1960 · 79 citations · Full text

A High‐Sensitivity 10‐Color Flow Cytometric Minimal Residual Disease Assay in B‐Lymphoblastic Leukemia/Lymphoma Can Easily Achieve the Sensitivity of 2‐in‐10<sup>6</sup>and Is Superior to Standard Minimal Residual Disease Assay: A Study of 622 Patients

Prashant Tembhare, Papagudi Ganesan Subramanian, Sitaram Ghogale et al. · Cytometry Part B Clinical Cytometry · 2019 · 74 citations · Full text

Evaluation of new markers for minimal residual disease monitoring in B‐cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000–000

Prashant Tembhare, Sitaram Ghogale, Nisha Ghatwai et al. · Cytometry Part B Clinical Cytometry · 2016 · 63 citations · Full text

Rows per page

1–5 of 34